                         SEQUENCE LISTING

<110>  Bionor Immuno AS
 
<120>  METHODS OF IMMUNIZATION

<130>  19277PCT00

<160>  71    

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  HIV

<400>  1

Ala Pro Thr Lys Ala Lys Arg Arg Val Val Gln Arg Glu Lys Arg Ala 
1               5                   10                  15      


Val 
    


<210>  2
<211>  17
<212>  PRT
<213>  HIV

<400>  2

Ala Pro Thr Lys Ala Lys Arg Arg Val Val Glu Arg Glu Lys Arg Ala 
1               5                   10                  15      


Val 
    


<210>  3
<211>  17
<212>  PRT
<213>  HIV

<400>  3

Ala Pro Thr Arg Ala Lys Arg Arg Val Val Gln Arg Glu Lys Arg Ala 
1               5                   10                  15      


Val 
    


<210>  4
<211>  17
<212>  PRT
<213>  HIV

<400>  4

Ala Pro Thr Arg Ala Lys Arg Arg Val Val Glu Arg Glu Lys Arg Ala 
1               5                   10                  15      


Val 
    


<210>  5
<211>  17
<212>  PRT
<213>  HIV

<400>  5

Ala Pro Thr Glu Ala Lys Arg Arg Val Val Glu Arg Glu Lys Arg Ala 
1               5                   10                  15      


Val 
    


<210>  6
<211>  15
<212>  PRT
<213>  HIV


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Glu can be Gly

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Gly can be Arg

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Arg can be Gln

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Asp can be Gly

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Arg can be Lys

<400>  6

Asp Arg Pro Glu Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Arg 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  HIV


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Glu can be Gly

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Gly can be Arg

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Arg can be Gln

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Asp can be Gly

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Arg can be Lys

<400>  7

Asp Arg Pro Glu Gly Ile Glu Asn Asn Gly Gly Glu Arg Asp Arg 
1               5                   10                  15  


<210>  8
<211>  12
<212>  PRT
<213>  HIV

<400>  8

Val Glu Arg Tyr Leu Lys Asp Gln Gln Leu Leu Gly 
1               5                   10          


<210>  9
<211>  12
<212>  PRT
<213>  HIV

<400>  9

Val Glu Arg Tyr Leu Lys Asp Glu Glu Leu Leu Gly 
1               5                   10          


<210>  10
<211>  12
<212>  PRT
<213>  HIV

<400>  10

Val Glu Arg Tyr Leu Lys Asp Asn Asn Leu Leu Gly 
1               5                   10          


<210>  11
<211>  15
<212>  PRT
<213>  HIV

<400>  11

Gln Leu Leu Leu Asn Gly Ser Leu Ala Glu Glu Glu Ile Val Ile 
1               5                   10                  15  


<210>  12
<211>  15
<212>  PRT
<213>  HIV

<400>  12

Gln Leu Leu Leu Asn Gly Ser Leu Ala Glu Glu Glu Val Val Ile 
1               5                   10                  15  


<210>  13
<211>  14
<212>  PRT
<213>  HIV

<400>  13

Gln Leu Leu Leu Asn Ser Leu Ala Glu Glu Glu Val Val Ile 
1               5                   10                  


<210>  14
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  14

Ala Pro Thr Lys Ala Lys Arg Gly Gly Gly Ala Pro Thr Arg Ala Lys 
1               5                   10                  15      


Arg Gly Gly Gly Ala Pro Thr Glu Ala Lys Arg 
            20                  25          


<210>  15
<211>  26
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  15

Arg Val Val Glu Arg Glu Lys Gly Gly Gly Ala Lys Arg Arg Val Val 
1               5                   10                  15      


Gly Gly Gly Arg Val Val Gln Arg Glu Lys 
            20                  25      


<210>  16
<211>  24
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  16

Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val Val 
1               5                   10                  15      


Gly Gln Arg Glu Lys Arg Ala Val 
            20                  


<210>  17
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  17

Cys Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val 
1               5                   10                  15      


Val Gly Gln Arg Glu Lys Arg Ala Val 
            20                  25  


<210>  18
<211>  23
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  18

Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val Val 
1               5                   10                  15      


Gly Gly Gln Arg Glu Lys Arg 
            20              


<210>  19
<211>  24
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Cys Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val 
1               5                   10                  15      


Val Gly Gly Gln Arg Glu Lys Arg 
            20                  


<210>  20
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  20

Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val Val 
1               5                   10                  15      


<210>  21
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  21

Gly Cys Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val 
1               5                   10                  15      


Val 
    


<210>  22
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  22

Gly Gly Gly Asp Gln Gln Leu Leu Gly Gly Ala Glu Glu Glu Ile Val 
1               5                   10                  15      


Gly Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Arg Asp Arg 
            20                  25                  30  


<210>  23
<211>  31
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  23

Cys Gly Gly Gly Asp Gln Gln Leu Leu Gly Gly Ala Glu Glu Glu Ile 
1               5                   10                  15      


Val Gly Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Arg Asp Arg 
            20                  25                  30      


<210>  24
<211>  22
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  24

Gly Gly Asp Gln Gln Leu Leu Gly Gly Ala Glu Glu Glu Ile Val Gly 
1               5                   10                  15      


Gly Gly Glu Arg Asp Arg 
            20          


<210>  25
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  25

Cys Gly Gly Gly Asp Gln Gln Leu Leu Gly Gly Ala Glu Glu Glu Ile 
1               5                   10                  15      


Val Gly Gly Ile Glu Glu Glu Gly Gly 
            20                  25  


<210>  26
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  26

Gly Gly Ala Glu Glu Glu Val Val Gly Gly Asp Gln Gln Leu Leu 
1               5                   10                  15  


<210>  27
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  27

Cys Gly Gly Ala Glu Glu Glu Val Val Gly Gly Asp Gln Gln Leu Leu 
1               5                   10                  15      


<210>  28
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  28

Cys Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val 
1               5                   10                  15      


Val Gly Gln Arg Glu Lys Arg Ala Val 
            20                  25  


<210>  29
<211>  31
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  29

Cys Gly Gly Gly Asp Gln Gln Leu Leu Gly Gly Ala Glu Glu Glu Ile 
1               5                   10                  15      


Val Gly Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Arg Asp Arg 
            20                  25                  30      


<210>  30
<211>  24
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  30

Cys Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg Val 
1               5                   10                  15      


Val Gly Gly Gln Arg Glu Lys Arg 
            20                  


<210>  31
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  31

Cys Gly Gly Gly Asp Gln Gln Leu Leu Gly Gly Ala Glu Glu Glu Ile 
1               5                   10                  15      


Val Gly Gly Ile Glu Glu Glu Gly Gly 
            20                  25  


<210>  32
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  32

Cys Gly Gly Ala Glu Glu Glu Val Val Gly Gly Asp Gln Gln Leu Leu 
1               5                   10                  15      


<210>  33
<211>  18
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  33

Gly Cys Gly Gly Ala Lys Arg Arg Val Val Gly Gly Ala Lys Arg Arg 
1               5                   10                  15      


Val Val 
        


<210>  34
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  34

Asp Gln Gln Leu Leu 
1               5   


<210>  35
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  35

Ala Lys Arg Arg Val Val 
1               5       


<210>  36
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  36

Ala Glu Glu Glu Val Val 
1               5       


<210>  37
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  37

Gly Gly Ala Ile Val Asn Gly Ser Leu Ala Asp Asp Asp Ile Val Ile 
1               5                   10                  15      


<210>  38
<211>  31
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Cys may be linked to Lys in position 2 in SEQ ID NO: 39 or 40 or 
       42 or 43

<400>  38

Gly Ala Lys Arg Arg Val Val Gly Gly Cys Gly Gly Ala Lys Arg Arg 
1               5                   10                  15      


Val Val Gln Arg Glu Lys Arg Ala Gly Glu Arg Glu Lys Arg Ala 
            20                  25                  30      


<210>  39
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MUTAGEN
<222>  (2)..(2)
<223>  Lys may be linked to Cys in position 10 in SEQ ID NO: 38 or 41

<400>  39

Gly Lys Gly Gly Ile Glu Glu Glu Gly Gly Arg Asp Arg Asp Arg Gly 
1               5                   10                  15      


Gly Glu Gln Asp Arg Asp Arg 
            20              


<210>  40
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Lys may be linked to Cys in position 10 in SEQ ID NO: 38 or 41

<400>  40

Gly Lys Gly Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Arg Asp Arg 
1               5                   10                  15      


Gly Gly Gln Asp Arg Asp Arg 
            20              


<210>  41
<211>  31
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Cys may be linked to Lys in position 2 in SEQ ID NO: 39 or 40 or 
       42 or 43

<400>  41

Gly Ala Lys Arg Arg Val Val Gly Gly Cys Gly Gly Ala Lys Arg Arg 
1               5                   10                  15      


Val Val Glu Arg Glu Lys Arg Ala Gly Gln Arg Glu Lys Arg Ala 
            20                  25                  30      


<210>  42
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Lys may be linked to Cys in position 10 in SEQ ID NO: 38 or 41

<400>  42

Gly Lys Gly Gly Ile Glu Glu Glu Gly Gly Gln Asp Arg Asp Arg Gly 
1               5                   10                  15      


Gly Arg Asp Arg Asp Arg 
            20          


<210>  43
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Lys may be linked to Cys in position 10 in SEQ ID NO: 38 or 41

<400>  43

Gly Lys Gly Gly Ile Glu Glu Glu Gly Gly Glu Gln Asp Arg Asp Arg 
1               5                   10                  15      


Gly Gly Glu Arg Asp Arg Asp 
            20              


<210>  44
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Trp may be D-Trp

<220>
<221>  DISULFID
<222>  (4)..(10)

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Carboxyterminal may be amidated

<400>  44

Trp Trp Gly Cys Ala Lys Arg Arg Val Cys Gly Gly Ala Lys Arg Arg 
1               5                   10                  15      


Val Val Gln Arg Glu Lys Arg Ala 
            20                  


<210>  45
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Trp may be D-Trp

<220>
<221>  DISULFID
<222>  (4)..(10)

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Carboxyterminus may be amidated

<400>  45

Trp Trp Gly Cys Ile Glu Glu Glu Gly Cys Gly Gly Ile Glu Glu Glu 
1               5                   10                  15      


Gly Gly Glu Arg Asp Arg 
            20          


<210>  46
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Glu can be Gly

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Gly can be Arg

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Arg can be Gln

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Asp can be Gly

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Arg can be Lys

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Asp can be Gly

<400>  46

Asp Arg Pro Glu Gly Ile Glu Asn Asn Gly Gly Glu Arg Asp Arg Asp 
1               5                   10                  15      


Arg 
    


<210>  47
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa in position 1 is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa in position 2 is Ala, Gly, Ser or Arg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa in position 3 is Leu or Met

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa in position 4 is Gly or Arg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa in position 5 is Pro, Thr, Val, Ser, Gln or Ala

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa in position 6 is Gly, Ala, Lys, Arg, Gln or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa in position 8 is Thr or Ser

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa in position 9 is Leu or Ile

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa in position 14 is Thr, Ser or Val

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa in position 15 is Ala or Ser

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa in position 16 is Cys or Ser

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa in position 17 is Gln or Leu

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa in position 18 is Gly, Glu or Arg

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa in position 20 is Gly or Arg

<400>  47

Xaa Xaa Xaa Xaa Xaa Xaa Ala Xaa Xaa Gln Thr Pro Trp Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Val Xaa 
            20  


<210>  48
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  48

Lys Ala Leu Gly Pro Gly Ala Thr Leu Gln Thr Pro Trp Thr Ala Cys 
1               5                   10                  15      


Gln Gly Val Gly 
            20  


<210>  49
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  49

Arg Ala Leu Gly Pro Ala Ala Thr Leu Gln Thr Pro Trp Thr Ala Ser 
1               5                   10                  15      


Leu Gly Val Gly 
            20  


<210>  50
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa in position 1 is Arg, Lys, Asp or none

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa in position 2 is Trp, Gly, Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa in position 3 is Ile, Leu, Val or Met

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa in position 4 is Ile, Val or Leu

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa in position 5 Leu, Met, Val or Pro

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa in position 12 is  0, 1, 2 or 3 Gly residues

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa in position 13 is Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa in position 14 is Met or Leu

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa in position 16 is Ser, Cys or Gln

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa in position 18 is Thr, Val, Ile, Ser or Ala

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa in position 19 is Ser, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa in position 22 is Asp, Glu, Cys or Gly

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa in position 22 is Gly or none

<400>  50

Xaa Xaa Xaa Xaa Xaa Gly Leu Asn Pro Leu Val Xaa Xaa Xaa Tyr Xaa 
1               5                   10                  15      


Pro Xaa Xaa Ile Leu Xaa Xaa 
            20              


<210>  51
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  51

Trp Ile Ile Pro Gly Leu Asn Pro Leu Val Gly Gly Gly Lys Leu Tyr 
1               5                   10                  15      


Ser Pro Thr Ser Ile Leu Cys Gly 
            20                  


<210>  52
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  52

Arg Trp Leu Leu Leu Gly Leu Asn Pro Leu Val Gly Gly Gly Arg Leu 
1               5                   10                  15      


Tyr Ser Pro Thr Ser Ile Leu Gly 
            20                  


<210>  53
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  53

Lys Ile Leu Leu Gly Leu Asn Pro Leu Val Gly Gly Gly Arg Leu Tyr 
1               5                   10                  15      


Ser Pro Thr Ser Ile Leu Gly 
            20              


<210>  54
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  54

Arg Leu Leu Leu Gly Leu Asn Pro Leu Val Gly Gly Gly Arg Leu Tyr 
1               5                   10                  15      


Ser Pro Thr Thr Ile Leu Gly 
            20              


<210>  55
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa in position 1 is Asn, Ser, Gly, His, Ala, Pro, Arg or none

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa in position 2 is Asn, Ala or Lys

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa in position 3 is Pro, Gln, Gly, Ile or Leu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa in position 7 is Val or Ala

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa in position 8 is Gly or Lys

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa in position 9 is Glu, Asp, Lys, Phe or Thr

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa in position 10 is Ile, Met, Val or Leu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa in position 11 is Tyr, Leu or none

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa in position 12 is Ser or none

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa in position 13 is 1, 2 or 3 Gly residues

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa in position 14 is Arg or none

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa in position 15 is Asp, Arg, Trp, Ala or none

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa in position 16 is Ile or none

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa in position 17 is Tyr or none

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa in position 18 is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa in position 19 is Arg, Lys or Asp

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa in position 20 is Trp or Gly

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa in position 21 is Ile, Met, Val, Gln or Ala

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa in position 22 is Ile, Val or Ala

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa in position 23 is Leu, Met or Val

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa in position 24 is Gly or Cys

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  Xaa in position 25 is Leu or none

<400>  55

Xaa Xaa Xaa Pro Ile Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25  


<210>  56
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  56

Arg Asn Ile Pro Ile Pro Val Gly Asp Ile Tyr Gly Gly Gly Asp Ile 
1               5                   10                  15      


Tyr Lys Arg Trp Gln Ala Leu Cys Leu 
            20                  25  


<210>  57
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  57

Arg Ala Ile Pro Ile Pro Ala Gly Thr Leu Leu Ser Gly Gly Gly Arg 
1               5                   10                  15      


Ala Ile Tyr Lys Arg Trp Ala Ile Leu Gly 
            20                  25      


<210>  58
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  58

Ala Leu Pro Ile Pro Ala Gly Phe Ile Tyr Gly Gly Gly Arg Ile Tyr 
1               5                   10                  15      


Lys Arg Trp Gln Ala Leu Gly 
            20              


<210>  59
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  59

Lys Ile Pro Ile Pro Val Gly Phe Ile Gly Gly Gly Trp Ile Tyr Lys 
1               5                   10                  15      


Arg Trp Ala Ile Leu Gly 
            20          


<210>  60
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  60

Lys Ile Pro Ile Pro Val Gly Thr Leu Leu Ser Gly Gly Gly Arg Ile 
1               5                   10                  15      


Tyr Lys Arg Trp Ala Ile Leu Gly 
            20                  


<210>  61
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa in position 1 is Pro, Lys, Arg or none

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa in position 2 is Glu, Arg, Phe or Lys

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa in position 5 is Pro or Thr

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa in position 6 is Met, Thr or Nleu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa in position 7 is Phe or Leu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa in position 8 is Ser, Thr, Ala or Met

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa in position 9 is Ala, Glu or Leu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa in position 11 is Ser or none

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa in position 12 is 1, 2 or 3 Gly residues

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa in position 12 is 0, 1, 2 or 3 Arg residues

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa in position 14 is Ala, Arg or none

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa in position 15 is Ile, Leu or none

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa in position 16 is Ser, Ala, Leu or none

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa in position 17 is Tyr, Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa in position 18 is Gly or Asp

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa in position 19 is Ala or Leu

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa in position 20 is Thr, Ile, Val, Leu or Asn

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa in position 21 is Pro, Thr or Ser

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa in position 22 is Tyr, Phe, Nleu, His or Gln

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa in position 23 is Asp, Asn, Leu or Ala

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa in position 24 is Leu, Ile, Val or Asn

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  Xaa in position 25 is Asn, Tyr, Cys or Gly

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  Xaa in position 26 is Thr, Met, Ile, Ala, Val or none

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa in postion 27 is Gly or none

<400>  61

Xaa Xaa Ile Ile Xaa Xaa Xaa Xaa Xaa Leu Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25          


<210>  62
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa in position 6 is Norleucine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa in position 21 is Norleucine

<400>  62

Lys Phe Ile Ile Pro Xaa Phe Ser Ala Leu Gly Gly Ala Ile Ser Tyr 
1               5                   10                  15      


Asp Leu Asn Thr Xaa Leu Asn Cys Ile 
            20                  25  


<210>  63
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa in position 6 is Norleucine

<400>  63

Lys Phe Ile Ile Pro Xaa Phe Ser Ala Leu Ser Gly Gly Gly Ala Ile 
1               5                   10                  15      


Ser Tyr Asp Leu Asn Thr Phe Leu Asn Cys Ile Gly 
            20                  25              


<210>  64
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa in position 6 is Norleucine

<400>  64

Arg Phe Ile Ile Pro Xaa Phe Thr Ala Leu Ser Gly Gly Arg Arg Ala 
1               5                   10                  15      


Leu Leu Tyr Gly Ala Thr Pro Tyr Ala Ile Gly 
            20                  25          


<210>  65
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa in position 5 is Norleucine

<400>  65

Lys Ile Ile Pro Xaa Phe Ser Ala Leu Gly Gly Gly Arg Leu Leu Tyr 
1               5                   10                  15      


Gly Ala Thr Pro Tyr Ala Ile Gly 
            20                  


<210>  66
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa in position 5 is Norleucine

<400>  66

Arg Ile Ile Pro Xaa Phe Thr Ala Leu Ser Gly Gly Gly Arg Leu Leu 
1               5                   10                  15      


Tyr Gly Ala Thr Pro Tyr Ala Ile Gly 
            20                  25  


<210>  67

<400>  67
000

<210>  68
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  68

Gly Lys Gly Gly Ile Glu Glu Glu Gly Gly Arg Asp Arg Asp Arg Gly 
1               5                   10                  15      


Gly Gln Asp Arg Asp Arg 
            20          


<210>  69

<400>  69
000

<210>  70
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  70

Asn Ile Pro Ile Pro Val Gly Asp Ile Tyr Gly Gly Gly Asp Ile Tyr 
1               5                   10                  15      


Lys Arg Trp Gln Ala Leu Cys Leu 
            20                  


<210>  71
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa in position 5 is Norleucine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa in position 20 is Norleucine

<400>  71

Trp Ile Ile Pro Xaa Phe Ser Ala Leu Gly Gly Ala Ile Ser Tyr Asp 
1               5                   10                  15      


Leu Asn Thr Xaa Leu Asn Cys Ile 
            20                  


